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Treatment of human amniotic ells (UAC) with Cytodex 1 (DEAE-dextran) results in the development of an antiviral 
state of the cells, as proven by studying (i) the cytopathic effect and (ii) pH]uridine incorporation i to the RNA of vesicu- 
lar stomatitis virus (VSV) after VSV infection. The same treatment transiently triggers the breakdown of inositol phos- 
pholipids and activates the translocation fprotein kinase C (PKC). On the basis of these data it can be suggested that 
cross-linking ofcell surface receptors by a solid carrier bearing covalently bound positive charges may result in IFN-like 
effects. 
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1. INTRODUCTION 
It is still an open problem whether entry of IFN 
into the cells is necessary for its action or binding 
to the membrane receptor is satisfactory in this 
respect. Experiments with matr ix-bound IFN 
demonstrated that surface-bound IFNs induce an 
antiviral effect [1,2]. A l though release of IFN 
from the carrier cannot be completely excluded in 
such experiments, on the basis of these and several 
other experimental data surface action of IFN was 
presumed [3]. In addit ion it was demonstrated that 
IFNs stimulate the turnover of membrane 
phosphatidyl inositol  and activate diacylglycerol 
and inositol tr isphosphate r lease [4,5]. 
There is evidence that cross-l inking of mem- 
brane IgM on resting B cells results in the 
hydrolysis of membrane phosphatidyl inositol 
4,5-bisphosphate [6,7]. One may presume, 
therefore, that cross-l inking of membrane surface 
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receptors by an insoluble matrix (Cytodex 1) carry- 
ing covalently bound positive charges will also pro- 
duce IFN-l ike effects. 
2. MATERIALS  AND METHODS 
UAC cells (a human amniotic ell line obtained from V. Sor- 
rentino, University of Rome, Italy) were grown in monolayer 
cultures using Parker's 199 medium or suspension cultures us- 
ing Eagle's medium, both containing 10% fetal calf serum. 
Cytodex 1 microcarrier of tissue cultures was developed by 
Pharmacia (Uppsala). Hu-IFNot (spec. act. 1.23 x 107 IU/mg 
protein) was manufactured byEGIS Pharmacochemical Works 
(Budapest). 
The Indiana strain of vesicular stomatitis virus (VSV) was 
plaque purified and passaged atlow multiplicities inUAC cells. 
To study the putative antiviral effect of Cytodex 1, suspen- 
sions of UAC cells (10 s cells/ml) were incubated overnight. 
After centrifuging, the cells were suspended in Eagle MEM (107 
cells/ml) containing-2% fetal calf serum and VSV to obtain in- 
fection at a multipficity of 1 PFU/cell. The virus was allowed 
to adsorb for 60 min. Four samples were then separated and 
tenfold diluted by Eagle's medium. Two of the samples were 
treated with 5 mg/ml Cytodex 1 (a dose found to be optimal in 
preliminary experiments) and two served as control. After 22 h 
incubation i  magnetic spinner vessels the samples were cen- 
trifuged at 2000 x g for 10 rain and the virus titres of the super- 
natants determined by the cytopathic effect on UAC cells grown 
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in Microtest TC plates (Falcon) and expressed in 50% tissue 
culture infectious doses (TCDIs0). 
Effect of Cytodex 1 on VSV-RNA replication in UAC cells 
was tested by measuring [3H]uridine incorporation i to the viral 
RNA in the presence of 5/bg/ml actinomycin D as described in 
detail elsewhere [8]. The effect of Cytodex 1 on the turnover of 
membrane phosphhtidylinositol was studied as described 
previously [9]. 
Phospholipid-dependent pro ein kinase C (PKC) activity was 
measured in the cytosol and in the detergent-solubilized mem- 
brane fraction according to Kikkawa et al. [10] as described in 
[9]. 
3. RESULTS AND DISCUSSION 
Fig.1 shows that in the supernatants of VSV- 
infected UAC cells treated with Cytodex 1 
significantly lower virus titers could be 
demonstrated. In separate xperiments we have 
found that adding of Cytodex to virus-containing 
suspensions does not reduce the virus titers as com- 
pared to control suspensions (not shown). 
Since it was reported recently that IFN treatment 
inhibits replication of VSV-RNA [11], it was 
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Fig.1. Effect of Cytodex 1 on virus multiplication in VSV- 
infected UAC cells. The results are presented as mean of VSV 
yield/0.1 ml logto + SE of three experiments measured by the 
cytopathic effect. (Details are given in section 2.) (o)  Control, 
VSV-infected but not treated cells; (11) VSV-infected cells 
treated with 5 mg/ml Cytodex 1. 
reasonable toinvestigate he effect of Cytodex 1 on 
the synthesis of VSV-RNA. 
Fig.2 shows that, similar to IFN, Cytodex 1 also 
inhibits [3H]uridine incorporation i to the VSV- 
RNA. This effect could be observed when addition 
of Cytodex 1 to the cells was performed 
simultaneously with virus infection, and when 
Cytodex 1 was given 16 h prior to virus infection. 
To exclude the possibility that Cytodex 1, as a 
weak anion exchanger, directly decreases the in- 
fecting capacity of the virus, virus suspensions 
were incubated with Cytodex 1 and after elimina- 
tion of Cytodex 1 UAC cells were infected with 
these viruses. We can state that this treatment did 
not alter the infecting ability of the viruses (not 
shown). 
As it was reported that IFNs stimulate the 
turnover of membrane phosphatidylinositol and 
transiently activate diacylglycerol and inositol 
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Fig.2. Effect of Cytodex 1 on VSV-RNA synthesis in UAC 
cells. Bars: 1, VSV*infected, actinomycin D-treated UAC cells; 
2, cells treated with 1000 IU/ml Hu-lFNtr for 16 h before virus 
infection; 3, cells treated with Cytodex 1 for 16 h before virus 
infection; 4, cells treated with Cytodex 1 simultaneously with 
virus infection. Each point represents he mean value + SD of 
[3H]uridine incorporation i to the viral RNA (n = 6). 
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trisphosphate r lease, it was important o deter- 
mine whether the observed inhibition of virus 
replication was due to the activation of this signal 
transduction mechanism. 
Fig.3 shows that after Cytodex 1 treatment the 
amounts of [3H]phosphatidylinositol 4-phosphate 
decrease in the membrane-phospholipid fraction 
of UAC cells, while the amounts of [3H]phosphati- 
dylinositol 4,5-phosphate significantly increase. 
The activity incorporated into the phosphatidyl- 
inositol fraction does not change considerably. 
Stimulation of membrane phosphatidylinositol 
turnover could also be demonstrated by measuring 
the amounts of water-soluble [3Hlinositol 
phosphates (rigA). 
It is known that several extracellular signals able 
to increase the breakdown of inositol phospho- 
lipids activate the association of PKC to the cell 
membrane [13,14]. Fig.5 demonstrates that 
Cytodex 1 also induces PKC transposition. 
The results of this study show that cross-linking 
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Fig.3. Changes of membrane phosphatidylinositol phosphates 
in UAC cells treated with 5 mg/ml Cytodex 1 for different 
intervals. Phosphatidylinositol phosphates (PI, phosphatidyl- 
inositol; PIP, phosphatidylinositol 4-phosphate; PIP2, phos- 
phatidylinositol 4,5-phosphate) were measured as described in 
detail in [9]. Counts (n = 3) were corrected for quenching and 
counting efficiency. (o) PI, (#) PIP, (A) PIP2. 
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Fig.4. Changes of inositol l-phosphate (o) and inositol 
trisphosphate ( ) in UAC cells treated with 5 mg/ml Cytodex 1 
for different intervals. Water-soluble metabolites were 
separated by anion-exchange chromatography according to 
Berridge et al. [1 1]. Counts (n = 3) are given in 070 of control 
values. 
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Fig.5. Effect of Cytodex 1 treatment of UAC cells on cytosolic 
(e) and particulate (o) PKC activity in function of time. Mean 
values of three experiments. Details of PKC assay are given in 
[9]. PKC activity was defined as that seen in the presence of 
CaCl2 and lipids minus that seen in the presence of EGTA. PKC 
activity is expressed as cpm of np  incorporated/2 min per total 
volume of each cytosolic and membrane preparation. 
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o f  cell surface receptors with Cytodex 1 (a solid 
matr ix  carrying covalently bound posit ive charges) 
activates the signal t ransduct ion mechanism in 
quest ion tr iggered general ly by specific biological  
substances. Thus, cross- l inking of  cell surface 
receptors by non-specif ic substances may result in 
an antiviral  state of  cells similar to that induced by 
IFNs.  
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